Cholangiocarcinoma
Tóm tắt
Từ khóa
Tài liệu tham khảo
Ishak, 1994
Carriaga, 1995, Liver, gallbladder, extrahepatic bile ducts, and pancreas, Cancer, 75, 171, 10.1002/1097-0142(19950101)75:1+<171::AID-CNCR2820751306>3.0.CO;2-2
Shaib, 2004, The epidemiology of cholangiocarcinoma, Semin Liver Dis, 24, 115, 10.1055/s-2004-828889
Khan, 2002, Changing international trends in mortality rates for liver, biliary and pancreatic tumours, J Hepatol, 37, 806, 10.1016/S0168-8278(02)00297-0
Patel, 2001, Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States, Hepatology, 33, 1353, 10.1053/jhep.2001.25087
Patel, 2002, Worldwide trends in mortality from biliary tract malignancies, BMC Cancer, 2, 10, 10.1186/1471-2407-2-10
Taylor-Robinson, 2001, Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968–1998, Gut, 48, 816, 10.1136/gut.48.6.816
Ishak, 1994
Nakeeb, 1996, Cholangiocarcinoma: a spectrum of intrahepatic, perihilar, and distal tumors, Ann Surg, 224, 463, 10.1097/00000658-199610000-00005
Khan, 2002, Guidelines for the diagnosis and management of cholangiocarcinoma, Gut, 51, VI1
2000
Vauthey, 1994, Recent advances in the management of cholangiocarcinomas, Semin Liver Dis, 14, 109, 10.1055/s-2007-1007302
Shaib, 2005, Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study, Gastroenterology, 128, 620, 10.1053/j.gastro.2004.12.048
Tullo, 2000, New p53 mutations in hilar cholangiocarcinoma, Eur J Clin Invest, 30, 798, 10.1046/j.1365-2362.2000.00717.x
Shaib, 2004, Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase?, J Hepatol, 40, 472, 10.1016/j.jhep.2003.11.030
Broome, 1996, Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis, Gut, 38, 610, 10.1136/gut.38.4.610
Bergquist, 1998, Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: a case-control study, Hepatology, 27, 311, 10.1002/hep.510270201
Chalasani, 2000, Cholangiocarcinoma in patients with primary sclerosing cholangitis: a multicenter case-control study, Hepatology, 31, 7, 10.1002/hep.510310103
Watanapa, 2002, Liver fluke-associated cholangiocarcinoma, Br J Surg, 89, 962, 10.1046/j.1365-2168.2002.02143.x
Watanapa, 1996, Cholangiocarcinoma in patients with opisthorchiasis, Br J Surg, 83, 1062, 10.1002/bjs.1800830809
Parkin, 1991, Liver cancer in Thailand I: a case-control study of cholangiocarcinoma, Int J Cancer, 48, 323, 10.1002/ijc.2910480302
Thamavit, 1978, Effects of dimethylnitrosamine on induction of cholangiocarcinoma in Opisthorchis viverrini-infected Syrian golden hamsters, Cancer Res, 38, 4634
Simeone, 1999, Gallbladder and biliary tree: anatomy and structural anomalies, 2244
Scott, 1980, Bile duct carcinoma: a late complication of congenital hepatic fibrosis: case report and review of literature, Am J Gastroenterol, 73, 113
Lipsett, 1994, Choledochal cyst disease: a changing pattern of presentation, Ann Surg, 220, 644, 10.1097/00000658-199411000-00007
van Mil, 2001, FIC1 disease: a spectrum of intrahepatic cholestatic disorders, Semin Liver Dis, 21, 535, 10.1055/s-2001-19034
Jacquemin, 2001, Role of multidrug resistance 3 deficiency in pediatric and adult liver disease: one gene for three diseases, Semin Liver Dis, 21, 551, 10.1055/s-2001-19033
Thompson, 2001, BSEP: function and role in progressive familial intrahepatic cholestasis, Semin Liver Dis., 21, 545, 10.1055/s-2001-19038
Meier, 2004, Hepatocellular malignancy in ABCB11/BStP disease (progressive familial intrahepatic cholestasis, type 2): four patients, Hepatology, 40, 471A
Kubo, 1995, Hepatolithiasis associated with cholangiocarcinoma, World J Surg, 19, 637, 10.1007/BF00294744
Chen, 1999, Peripheral cholangiocarcinoma (cholangiocellular carcinoma): clinical features, diagnosis and treatment, J Gastroenterol Hepatol, 14, 1144, 10.1046/j.1440-1746.1999.01983.x
Okuda, 2002, Cholangiocarcinoma: recent progress. Part 1: epidemiology and etiology, J Gastroenterol Hepatol, 17, 1049, 10.1046/j.1440-1746.2002.02781.x
Khan, 2003, DNA adducts, detected by 32P postlabelling, in human cholangiocarcinoma, Gut, 52, 586, 10.1136/gut.52.4.586
Sahani, 2003, Thorotrast-induced cholangiocarcinoma: case report, Abdom Imaging, 28, 72, 10.1007/s00261-001-0148-y
Hardell, 1984, Aetiological aspects on primary liver cancer with special regard to alcohol, organic solvents and acute intermittent porphyria: an epidemiological investigation, Br J Cancer, 50, 389, 10.1038/bjc.1984.188
Sorensen, 1998, Risk of liver and other types of cancer in patients with cirrhosis: a nationwide cohort study in Denmark, Hepatology, 28, 921, 10.1002/hep.510280404
Shin, 1996, Hepatitis B and C virus, Clonorchis sinensis for the risk of liver cancer: a case-control study in Pusan, Korea, Int J Epidemiol, 25, 933, 10.1093/ije/25.5.933
Donato, 2001, Intrahepatic cholangiocarcinoma and hepatitis C and B virus infection, alcohol intake, and hepatolithiasis: a case-control study in Italy, Cancer Causes Control, 12, 959, 10.1023/A:1013747228572
Kobayashi, 2000, Incidence of primary cholangiocellular carcinoma of the liver in japanese patients with hepatitis C virus-related cirrhosis, Cancer, 88, 2471, 10.1002/1097-0142(20000601)88:11<2471::AID-CNCR7>3.0.CO;2-T
Yin, 1998, Detection of hepatitis C virus RNA sequences in hepatic portal cholangiocarcinoma tissue by reverse transcription polymerase chain reaction, Chin Med J (Engl), 111, 1068
Berthiaume, 2004, The molecular pathogenesis of cholangiocarcinoma, Semin Liver Dis, 24, 127, 10.1055/s-2004-828890
Nehls, 2004, Serum and bile markers for cholangiocarcinoma, Semin Liver Dis, 24, 139, 10.1055/s-2004-828891
Isa, 2002, Analysis of microsatellite instability, K-ras gene mutation and p53 protein overexpression in intrahepatic cholangiocarcinoma, Hepatogastroenterol, 49, 604
Wang, 2002, Usefulness of p53 gene mutations in the supernatant of bile for diagnosis of biliary tract carcinoma: comparison with K-ras mutation, J Gastroenterol, 37, 831, 10.1007/s005350200137
Itoi, 1999, K-ras codon 12 and p53 mutations in biopsy specimens and bile from biliary tract cancers, Pathol Int, 49, 30, 10.1046/j.1440-1827.1999.00821.x
Aishima, 2002, c-erbB-2 and c-Met expression relates to cholangiocarcinogenesis and progression of intrahepatic cholangiocarcinoma, Histopathology, 40, 269, 10.1046/j.1365-2559.2002.00353.x
Harnois, 1997, Bcl-2 is overexpressed and alters the threshold for apoptosis in a cholangiocarcinoma cell line, Hepatology, 26, 884, 10.1002/hep.510260413
Okaro, 2001, The expression of anti-apoptotic proteins (Bcl-2, Bcl-xl, Mcl-1) by benign, dysplastic and malignant biliary epithelium, J Clin Pathol, 54, 927, 10.1136/jcp.54.12.927
Taniai, 2002, p16INK4a promoter mutations are frequent in primary sclerosing cholangitis (PSC) and PSC-associated cholangiocarcinoma, Gastroenterol, 123, 1090, 10.1053/gast.2002.36021
van Leeuwen, 1999, Primary sclerosing cholangitis and cholangiocarcinoma as a diagnostic and therapeutic dilemma, Ann Oncol, 10, 89, 10.1093/annonc/10.suppl_4.S89
Jarnagin, 2004, Surgical management of cholangiocarcinoma, Semin Liver Dis, 24, 189, 10.1055/s-2004-828895
Anderson, 2004, Diagnosis and treatment of cholangiocarcinoma, Oncologist, 9, 43, 10.1634/theoncologist.9-1-43
Patel, 2000, The utility of CA 19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis, Am J Gastroenterol, 95, 204, 10.1111/j.1572-0241.2000.01685.x
Lamerz, 1999, Role of tumour markers, cytogenetics, Ann Oncol, 10, 145, 10.1093/annonc/10.suppl_4.S145
Albert, 1988, Elevated serum levels of tumor marker CA19-9 in acute cholangitis, Dig Dis Sci, 33, 1223, 10.1007/BF01536670
Siqueira, 2002, Detecting cholangiocarcinoma in patients with primary sclerosing cholangitis, Gastrointest Endosc, 56, 40, 10.1067/mge.2002.125105
Ramage, 1995, Serum tumor markers for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis, Gastroenterol, 108, 865, 10.1016/0016-5085(95)90462-X
Saini, 1997, Imaging of the hepatobiliary tract, N Engl J Med, 336, 1889, 10.1056/NEJM199706263362607
Valls, 2000, Intrahepatic peripheral cholangiocarcinoma: CT evaluation, Abdom Imaging, 25, 490, 10.1007/s002610000079
Zhang, 1999, Intrahepatic peripheral cholangiocarcinoma: comparison of dynamic CT and dynamic MRI, J Comput Assist Tomogr, 23, 670, 10.1097/00004728-199909000-00004
Yeh, 2000, Malignant perihilar biliary obstruction: magnetic resonance cholangiopancreatographic findings, Am J Gastroenterol, 95, 432, 10.1111/j.1572-0241.2000.01763.x
Manfredi, 2004, Magnetic resonance imaging of cholangiocarcinoma, Semin Liver Dis, 24, 155, 10.1055/s-2004-828892
Manfredi, 2001, [Malignant biliary hilar stenosis: MR cholangiography compared with direct cholangiography], Radiol Med (Torino), 102, 48
Zidi, 2000, Performance characteristics of magnetic resonance cholangiography in the staging of malignant hilar strictures, Gut, 46, 103, 10.1136/gut.46.1.103
Baron, 2004, A prospective comparison of digital image analysis and routine cytology for the identification of malignancy in biliary tract strictures, Clin Gastroenterol Hepatol, 2, 214, 10.1016/S1542-3565(04)00006-0
Abu-Hamda, 2004, Endoscopic management of cholangiocarcinoma, Semin Liver Dis, 24, 165, 10.1055/s-2004-828893
Anderson, 2004, Fluorodeoxyglucose PET imaging in the evaluation of gallbladder carcinoma and cholangiocarcinoma, J Gastrointest Surg, 8, 90, 10.1016/j.gassur.2003.10.003
Kato, 2002, Clinical role of (18)F-FDG PET for initial staging of patients with extrahepatic bile duct cancer, Eur J Nucl Med Mol Imaging, 29, 1047, 10.1007/s00259-002-0852-z
Kim, 2003, Usefulness of 18F-FDG PET in intrahepatic cholangiocarcinoma, Eur J Nucl Med Mol Imaging, 30, 1467, 10.1007/s00259-003-1297-8
Fritscher-Ravens, 2001, FDG PET in the diagnosis of hilar cholangiocarcinoma, Nucl Med Commun, 22, 1277, 10.1097/00006231-200112000-00002
Bismuth, 1992, Management strategies in resection for hilar cholangiocarcinoma, Ann Surg, 215, 31, 10.1097/00000658-199201000-00005
Burke, 1998, Hilar Cholangiocarcinoma: patterns of spread, the importance of hepatic resection for curative operation, and a presurgical clinical staging system, Ann Surg, 228, 385, 10.1097/00000658-199809000-00011
Jarnagin, 2001, Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma, Ann Surg, 234, 507, 10.1097/00000658-200110000-00010
Ebata, 2003, Hepatectomy with portal vein resection for hilar cholangiocarcinoma: audit of 52 consecutive cases, Ann Surg, 238, 720, 10.1097/01.sla.0000094437.68038.a3
Corvera, 2002, Role of laparoscopy in the evaluation of biliary tract cancer, Surg Oncol Clin N Am, 11, 877, 10.1016/S1055-3207(02)00033-9
Su, 1996, Factors influencing postoperative morbidity, mortality, and survival after resection for hilar cholangiocarcinoma, Ann Surg, 223, 384, 10.1097/00000658-199604000-00007
Cameron, 1990, Management of proximal cholangiocarcinomas by surgical resection and radiotherapy, Am J Surg, 159, 91, 10.1016/S0002-9610(05)80612-9
Nimura, 1990, Hepatic segmentectomy with caudate lobe resection for bile duct carcinoma of the hepatic hilus, World J Surg, 14, 535, 10.1007/BF01658686
Nakeeb, 2002, Improved survival in resected biliary malignancies, Surgery, 132, 555, 10.1067/msy.2002.127555
Nimura, 2000, Aggressive preoperative management and extended surgery for hilar cholangiocarcinoma: Nagoya experience, J Hepatobiliary Pancreat Surg, 7, 155, 10.1007/s005340050170
Hadjis, 1990, Outcome of radical surgery in hilar cholangiocarcinoma, Surgery, 107, 597
Pichlmayr, 1996, Surgical treatment in proximal bile duct cancer: a single-center experience, Ann Surg, 224, 628, 10.1097/00000658-199611000-00007
Lillemoe, 2000, Surgery for hilar cholangiocarcinoma: the Johns Hopkins approach. J Hepatobiliary, Pancreat Surg, 7, 115, 10.1007/s005340050164
Fong, 1996, Outcome of treatment for distal bile duct cancer, Br J Surg, 83, 1712, 10.1002/bjs.1800831217
Wade, 1997, Experience with distal bile duct cancers in U.S. Veterans Affairs hospitals: 1987–1991, J Surg Oncol, 64, 242, 10.1002/(SICI)1096-9098(199703)64:3<242::AID-JSO12>3.0.CO;2-6
Kitagawa, 2001, Lymph node metastasis from hilar cholangiocarcinoma: audit of 110 patients who underwent regional and para-aortic node dissection, Ann Surg, 233, 385, 10.1097/00000658-200103000-00013
Figueras, 2000, Changing strategies in diagnosis and management of hilar cholangiocarcinoma, Liver Transpl, 6, 786, 10.1053/jlts.2000.18507
Hemming, 2003, Preoperative portal vein embolization for extended hepatectomy, Ann Surg, 237, 686, 10.1097/01.SLA.0000065265.16728.C0
Abdalla, 2002, Extended hepatectomy in patients with hepatobiliary malignancies with and without preoperative portal vein embolization, Arch Surg, 137, 675, 10.1001/archsurg.137.6.675
Todoroki, 2000, Benefits of adjuvant radiotherapy after radical resection of locally advanced main hepatic duct carcinoma, Int J Radiat Oncol Biol Phys, 46, 581, 10.1016/S0360-3016(99)00472-1
Gonzalez Gonzalez, 1999, Role of radiotherapy, in particular intraluminal brachytherapy, in the treatment of proximal bile duct carcinoma, Ann Oncol, 10, 215, 10.1093/annonc/10.suppl_4.S215
Pitt, 1995, Perihilar cholangiocarcinoma: postoperative radiotherapy does not improve survival, Ann Surg, 221, 788, 10.1097/00000658-199506000-00017
Meyer, 2000, Liver transplantation for cholangiocarcinoma: results in 207 patients, Transplantation, 69, 1633, 10.1097/00007890-200004270-00019
Jeyarajah, 1998, Is liver transplantation indicated for cholangiocarcinoma?, J Hepatobiliary Pancreat Surg, 5, 48, 10.1007/PL00009950
Heimbach, 2004, Liver transplantation for unresectable perihilar cholangiocarcinoma, Semin Liver Dis, 24, 201, 10.1055/s-2004-828896
Farley, 1995, “Natural history” of unresected cholangiocarcinoma: patient outcome after noncurative intervention, Mayo Clin Proc, 70, 425, 10.4065/70.5.425
Berr, 2004, Photodynamic therapy for cholangiocarcinoma, Semin Liver Dis, 24, 177, 10.1055/s-2004-828894
Chang, 1998, Outcome in patients with bifurcation tumors who undergo unilateral versus bilateral hepatic duct drainage, Gastrointest Endosc, 47, 354, 10.1016/S0016-5107(98)70218-4
Chari, 2003, Treatment of cholangiocarcinoma II
Prat, 1998, Predictive factors for survival of patients with inoperable malignant distal biliary strictures: a practical management guideline, Gut, 42, 76, 10.1136/gut.42.1.76
Cheung, 1995, Endoscopic stenting for malignant biliary obstruction, Arch Surg, 130, 204, 10.1001/archsurg.1995.01430020094018
Schima, 1997, Biliary Wallstent endoprosthesis in malignant hilar obstruction: long-term results with regard to the type of obstruction, Clin Radiol, 52, 213, 10.1016/S0009-9260(97)80275-9
Kaassis, 2003, Plastic or metal stents for malignant stricture of the common bile duct? Results of a randomized prospective study, Gastrointest Endosc, 57, 178, 10.1067/mge.2003.66
Dowsett, 1989, Endoscopic biliary therapy using the combined percutaneous and endoscopic technique, Gastroenterol, 96, 1180, 10.1016/0016-5085(89)91639-9
Deviere, 1988, Long-term follow-up of patients with hilar malignant stricture treated by endoscopic internal biliary drainage, Gastrointest Endosc, 34, 95, 10.1016/S0016-5107(88)71271-7
De Palma, 2001, Unilateral versus bilateral endoscopic hepatic duct drainage in patients with malignant hilar biliary obstruction: results of a prospective, randomized, and controlled study, Gastrointest Endosc, 53, 547, 10.1067/mge.2001.113381
De Palma, 2003, Unilateral placement of metallic stents for malignant hilar obstruction: a prospective study, Gastrointest Endosc, 58, 50, 10.1067/mge.2003.310
Freeman, 2003, Selective MRCP and CT-targeted drainage of malignant hilar biliary obstruction with self-expanding metallic stents, Gastrointest Endosc, 58, 41, 10.1067/mge.2003.292
Isayama, 2004, A prospective randomised study of “covered” versus “uncovered” diamond stents for the management of distal malignant biliary obstruction, Gut, 53, 729, 10.1136/gut.2003.018945
Sung, 2004, Commentary, Nature Clin Prac, Gastro & Hep, 1, 21
Ohnishi, 1995, External radiotherapy for biliary decompression of hilar cholangiocarcinoma, Hepatogastroenterol, 42, 265
Gerhards, 2003, Results of postoperative radiotherapy for resectable hilar cholangiocarcinoma, World J Surg, 27, 173, 10.1007/s00268-002-6434-1
Patt, 2001, Phase II trial of cisplatin, interferon alpha-2b, doxorubicin, and 5-fluorouracil for biliary tract cancer, Clin Cancer Res, 7, 3375
Choi, 2000, Effects of 5-fluorouracil and leucovorin in the treatment of pancreatic-biliary tract adenocarcinomas, Am J Clin Oncol, 23, 425, 10.1097/00000421-200008000-00023
Ducreux, 1998, Effective treatment of advanced biliary tract carcinoma using 5-fluorouracil continuous infusion with cisplatin, Ann Oncol, 9, 653, 10.1023/A:1008241008379
Ellis, 1995, Epirubicin, cisplatin and infusional 5-fluorouracil (5-FU) (ECF) in hepatobiliary tumours, Eur J Cancer, 31A, 1594, 10.1016/0959-8049(95)00323-B
Nehls, 2002, Oxaliplatin, fluorouracil and leucovorin for advanced biliary system adenocarcinomas: a prospective phase II trial, Br J Cancer, 87, 702, 10.1038/sj.bjc.6600543
Gebbia, 2001, Treatment of inoperable and/or metastatic biliary tree carcinomas with single-agent gemcitabine or in combination with levofolinic acid and infusional fluorouracil: results of a multicenter phase II study, J Clin Oncol, 19, 4089, 10.1200/JCO.2001.19.20.4089
Papakostas, 2001, First-line chemotherapy with docetaxel for unresectable or metastatic carcinoma of the biliary tract: a multicentre phase II study, Eur J Cancer, 37, 1833, 10.1016/S0959-8049(01)00214-3
Dowlati, 2003, Multicenter phase II and pharmacokinetic study of rebeccamycin analogue in advanced biliary cancers, Proc Am Soc Clin Oncol, 22, 267a
Thongprasert, 2005, Phase II study of gemcitabine and cisplatin as first-line chemotherapy in inoperable biliary tract carcinoma, Ann Oncol, 16, 279, 10.1093/annonc/mdi046
Knox, 2005, Combining gemcitabine and capecitabine in patients with advanced biliary cancer: a phase II trial, J Clin Oncol, 23, 2332, 10.1200/JCO.2005.51.008
Ortner, 2003, Successful photodynamic therapy for non-resectable cholangiocarcinoma: a randomized prospective study, Gastroenterol, 125, 1355, 10.1016/j.gastro.2003.07.015